Spots Global Cancer Trial Database for Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical Cancer
Official Title: Preoperative Concurrent Chemoradiotherapy Combined With Nimotuzumab Injection for Locally Advanced Cervical Cancer: a Phase II Study
Study ID: NCT01938105
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine the feasibility and efficacy of preoperative nimotuzumab injection combined with concurrent chemoradiotherapy for initially inoperable, locally advanced cervical cancer.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China
Contact Details
Name: Heming Lu, MS
Affiliation: People's Hospital of Guangxi
Role: STUDY_CHAIR
Name: Heming Lu, MS
Affiliation: People's Hospital of Guangxi
Role: PRINCIPAL_INVESTIGATOR
Name: Yun Mo, MS
Affiliation: People's Hospital of Guangxi
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
